In the KA-induced epilepsy model, OLFM3-LV injection shortened the spontaneous seizure onset latency, while OLFM3-shRNA injection prolonged the onset latency compared with Con-sh injection (Figure 3C). The gene discussed is OLFM3; the disease is epilepsy.